Stability of chloramphenicol metabolites in human blood and liver as determined by high-performance liquid chromatography

Wafa H. Abou-Khalil, Adel A Yunis, Samir Abou-Khalil

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The pathogenesis of aplastic anemia from chloramphenicol (CAP) remains uncertain. Recent observations suggest that metabolites of CAP generated by intestinal bacteria may play an important role in mediating hematotoxicity from the drug. Thus, it is possible that once in circulation and after passage through the liver, some CAP metabolites may gain access to the marrow causing hematotoxicity. Based on this possibility, we have studied the stability of CAP and the three cytotoxic analogues dehydrochloramphenicol (DH-CAP), nitrophenylaminopropanedione (NPAP) and nitroso-chloramphenicol (NOCAP) in human blood and liver. Determination of these compounds was accomplished by using a high-performance liquid chromatography system uniquely suited for their separation and detection. Several methods for deproteinization were utilized in order to ensure a full quantitative extraction of the drugs. At zero time, a 100% recovery of CAP, DH-CAP and NPAP was reached with acetonitrile (1 vol/3 vol); whereas NO-CAP was slightly or not detectable with all methods. Incubation of CAP and analogues with blood or liver at 37 °C for up to 30 min showed the following: CAP was stable in both tissues with full recovery; DH-CAP was stable for 5 min, then gradually decreased reaching 50 or 70% of the initial amount after 30 min of incubation with blood and liver, respectively; NPAP decreased at a faster rate than DH-CAP, and NO-CAP completely disappeared. The data suggest that if and when formed in the body, DH-CAP and NPAP may stay in the circulation long enough to reach the marrow and interact with its cellular components.

Original languageEnglish (US)
Pages (from-to)272-278
Number of pages7
JournalPharmacology
Volume36
Issue number4
DOIs
StatePublished - 1988

Fingerprint

Chloramphenicol
High Pressure Liquid Chromatography
Liver
Bone Marrow
Aplastic Anemia
Pharmaceutical Preparations
dehydrochloramphenicol
Bacteria
1-(4-nitrophenyl)-2-amino-1,3-propandedione

Keywords

  • Blood
  • Chloramphenicol metabolites
  • High-performance liquid chromatography
  • Liver
  • Stability

ASJC Scopus subject areas

  • Pharmacology

Cite this

Stability of chloramphenicol metabolites in human blood and liver as determined by high-performance liquid chromatography. / Abou-Khalil, Wafa H.; Yunis, Adel A; Abou-Khalil, Samir.

In: Pharmacology, Vol. 36, No. 4, 1988, p. 272-278.

Research output: Contribution to journalArticle

Abou-Khalil, Wafa H. ; Yunis, Adel A ; Abou-Khalil, Samir. / Stability of chloramphenicol metabolites in human blood and liver as determined by high-performance liquid chromatography. In: Pharmacology. 1988 ; Vol. 36, No. 4. pp. 272-278.
@article{e8e5165d5e434de5a6a4ded6dc4a5be7,
title = "Stability of chloramphenicol metabolites in human blood and liver as determined by high-performance liquid chromatography",
abstract = "The pathogenesis of aplastic anemia from chloramphenicol (CAP) remains uncertain. Recent observations suggest that metabolites of CAP generated by intestinal bacteria may play an important role in mediating hematotoxicity from the drug. Thus, it is possible that once in circulation and after passage through the liver, some CAP metabolites may gain access to the marrow causing hematotoxicity. Based on this possibility, we have studied the stability of CAP and the three cytotoxic analogues dehydrochloramphenicol (DH-CAP), nitrophenylaminopropanedione (NPAP) and nitroso-chloramphenicol (NOCAP) in human blood and liver. Determination of these compounds was accomplished by using a high-performance liquid chromatography system uniquely suited for their separation and detection. Several methods for deproteinization were utilized in order to ensure a full quantitative extraction of the drugs. At zero time, a 100{\%} recovery of CAP, DH-CAP and NPAP was reached with acetonitrile (1 vol/3 vol); whereas NO-CAP was slightly or not detectable with all methods. Incubation of CAP and analogues with blood or liver at 37 °C for up to 30 min showed the following: CAP was stable in both tissues with full recovery; DH-CAP was stable for 5 min, then gradually decreased reaching 50 or 70{\%} of the initial amount after 30 min of incubation with blood and liver, respectively; NPAP decreased at a faster rate than DH-CAP, and NO-CAP completely disappeared. The data suggest that if and when formed in the body, DH-CAP and NPAP may stay in the circulation long enough to reach the marrow and interact with its cellular components.",
keywords = "Blood, Chloramphenicol metabolites, High-performance liquid chromatography, Liver, Stability",
author = "Abou-Khalil, {Wafa H.} and Yunis, {Adel A} and Samir Abou-Khalil",
year = "1988",
doi = "10.1159/000138394",
language = "English (US)",
volume = "36",
pages = "272--278",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Stability of chloramphenicol metabolites in human blood and liver as determined by high-performance liquid chromatography

AU - Abou-Khalil, Wafa H.

AU - Yunis, Adel A

AU - Abou-Khalil, Samir

PY - 1988

Y1 - 1988

N2 - The pathogenesis of aplastic anemia from chloramphenicol (CAP) remains uncertain. Recent observations suggest that metabolites of CAP generated by intestinal bacteria may play an important role in mediating hematotoxicity from the drug. Thus, it is possible that once in circulation and after passage through the liver, some CAP metabolites may gain access to the marrow causing hematotoxicity. Based on this possibility, we have studied the stability of CAP and the three cytotoxic analogues dehydrochloramphenicol (DH-CAP), nitrophenylaminopropanedione (NPAP) and nitroso-chloramphenicol (NOCAP) in human blood and liver. Determination of these compounds was accomplished by using a high-performance liquid chromatography system uniquely suited for their separation and detection. Several methods for deproteinization were utilized in order to ensure a full quantitative extraction of the drugs. At zero time, a 100% recovery of CAP, DH-CAP and NPAP was reached with acetonitrile (1 vol/3 vol); whereas NO-CAP was slightly or not detectable with all methods. Incubation of CAP and analogues with blood or liver at 37 °C for up to 30 min showed the following: CAP was stable in both tissues with full recovery; DH-CAP was stable for 5 min, then gradually decreased reaching 50 or 70% of the initial amount after 30 min of incubation with blood and liver, respectively; NPAP decreased at a faster rate than DH-CAP, and NO-CAP completely disappeared. The data suggest that if and when formed in the body, DH-CAP and NPAP may stay in the circulation long enough to reach the marrow and interact with its cellular components.

AB - The pathogenesis of aplastic anemia from chloramphenicol (CAP) remains uncertain. Recent observations suggest that metabolites of CAP generated by intestinal bacteria may play an important role in mediating hematotoxicity from the drug. Thus, it is possible that once in circulation and after passage through the liver, some CAP metabolites may gain access to the marrow causing hematotoxicity. Based on this possibility, we have studied the stability of CAP and the three cytotoxic analogues dehydrochloramphenicol (DH-CAP), nitrophenylaminopropanedione (NPAP) and nitroso-chloramphenicol (NOCAP) in human blood and liver. Determination of these compounds was accomplished by using a high-performance liquid chromatography system uniquely suited for their separation and detection. Several methods for deproteinization were utilized in order to ensure a full quantitative extraction of the drugs. At zero time, a 100% recovery of CAP, DH-CAP and NPAP was reached with acetonitrile (1 vol/3 vol); whereas NO-CAP was slightly or not detectable with all methods. Incubation of CAP and analogues with blood or liver at 37 °C for up to 30 min showed the following: CAP was stable in both tissues with full recovery; DH-CAP was stable for 5 min, then gradually decreased reaching 50 or 70% of the initial amount after 30 min of incubation with blood and liver, respectively; NPAP decreased at a faster rate than DH-CAP, and NO-CAP completely disappeared. The data suggest that if and when formed in the body, DH-CAP and NPAP may stay in the circulation long enough to reach the marrow and interact with its cellular components.

KW - Blood

KW - Chloramphenicol metabolites

KW - High-performance liquid chromatography

KW - Liver

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=0023866853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023866853&partnerID=8YFLogxK

U2 - 10.1159/000138394

DO - 10.1159/000138394

M3 - Article

C2 - 3380880

AN - SCOPUS:0023866853

VL - 36

SP - 272

EP - 278

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 4

ER -